Objectives

After participating in this educational activity, attendees should be able to:

1. Describe delirium and the causes, treatment, and preventative measures
2. Interpret the results of the journal article titled “Efficacy of low-dose prophylactic quetiapine on delirium prevention in critically ill patients”
3. Formulate an informed decision if prophylactic quetiapine should be used to prevent delirium in the ICU

Faculty

Anna Morien, PharmD
PGY2 Critical Care Pharmacy Resident
Pharmacist
Baystate Medical Center

Faculty Disclosure

The design and content of Baystate Continuing Interprofessional Education ( CE ) activities support quality improvement in healthcare and provide fair and balanced views of therapeutic options.  Faculty or planner conflicts of interest are resolved before the educational activity.

None of the members of the faculty and planning committee for this educational event have commercial relationships with any entity producing, marketing, re-selling or distributing health care goods and services consumed by or used on patients.